Please enable JavaScript to continue using this application.

Compare $ATRA vs $HSTC | Chartloom

Compare

$ATRA vs $HSTC

Atara Biotherapeutics Inc · HST Global Inc

ATRA

Atara Biotherapeutics Inc

HSTC

HST Global Inc

Compare $ATRA vs $HSTC

Comparing Atara Biotherapeutics Inc and HST Global Inc

ATRAAtara Biotherapeutics Inc

HSTCHST Global Inc

ATRAAtara Biotherapeutics Inc

Market cap

$85M

P/E (TTM)

—

Forward P/E (NTM)

14.78x

Forward P/S (NTM)

2.47x

Rev growth (TTM)

-96.7%

YTD performance

-46.7%

52W performance

-40.2%

FCF yield

-25.6%

HSTCHST Global Inc

Market cap

$99M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-29.3%

52W performance

438.5%

FCF yield

-0.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ATRA

HSTC

Detailed metrics comparison

ATRA

Atara Biotherapeutics Inc

HSTC

HST Global Inc

Market Cap

ATRA$85M

HSTC$99M

Enterprise Value

ATRA$124M

HSTC$99M

Price

ATRA$9.48

HSTC$0.70

P/E Ratio

ATRAN/A

HSTCN/A

P/S Ratio

ATRA13.79x

HSTC6.52x

EV/Sales

ATRA19.98x

HSTC0.00x

EV/EBITDA

ATRA3.51x

HSTC227.13x

P/B Ratio

ATRA12.86x

HSTC17.75x

P/FCF Ratio

ATRAN/A

HSTCN/A

EV/FCF

ATRA-5.65x

HSTC-782.53x

PEG Ratio

ATRAN/A

HSTCN/A

Forward P/E (NTM)

ATRA14.78x

HSTCN/A

Forward P/S (NTM)

ATRA2.47x

HSTCN/A

Revenue (TTM)

ATRA$6M

HSTC$0

Revenue Growth (YoY)

ATRA-96.7%

HSTCN/A

Forward Rev Growth

ATRA1983.2%

HSTC0.0%

Gross Margin (TTM)

ATRA91.4%

HSTC0.0%

Operating Margin (TTM)

ATRA0.0%

HSTC0.0%

EBITDA Margin (TTM)

ATRA-194.7%

HSTC0.0%

Net Margin (TTM)

ATRA-269.4%

HSTC0.0%

FCF Margin (TTM)

ATRA-353.5%

HSTCN/A

Net Income (TTM)

ATRA$-17M

HSTC$-51K

FCF (TTM)

ATRA$-22M

HSTC$-127K

EPS (TTM)

ATRA-$1.11

HSTC$0.00

ROE (TTM)

ATRA-31542.0%

HSTC2453.5%

ROA (TTM)

ATRA-7301.0%

HSTC-349482.0%

ROIC (TTM)

ATRA-30684.0%

HSTC2453.5%

Cash

ATRA$3M

HSTC$29K

Debt

ATRA$42M

HSTC$252K

Net Cash/Debt

ATRA$-38M

HSTC$-224K

Current Ratio (TTM)

ATRA1.98x

HSTC0.08x

Quick Ratio (TTM)

ATRA1.98x

HSTC0.08x

Debt/Equity (TTM)

ATRA0.12x

HSTC0.05x

Debt/Assets (TTM)

ATRA0.0%

HSTC0.0%

Interest Coverage (TTM)

ATRAN/A

HSTCN/A

Net Debt/EBITDA (TTM)

ATRA0.00x

HSTC0.00x

Beta

ATRA0.31

HSTC-349.46

52W Performance

ATRA-40.2%

HSTC438.5%

YTD Performance

ATRA-46.7%

HSTC-29.3%

% from 52W High

ATRA-50.5%

HSTC-39.1%

% from 52W Low

ATRA141.8%

HSTC699900.0%

Asset Turnover (TTM)

ATRA0.27x

HSTC0.79x

FCF Yield (TTM)

ATRA-25.6%

HSTC-0.1%

Earnings Yield (TTM)

ATRA-19.5%

HSTC-0.1%

Dividend Yield (TTM)

ATRAN/A

HSTCN/A

Rule of 40

ATRA-450.2

HSTC0.0

EV/GP/RG

ATRA0.05

HSTCN/A

Ticker research

View ATRA research View HSTC research

Metric	ATRA Atara Biotherapeutics Inc	HSTC HST Global Inc
Market & Valuation
Market Cap	$85M	$99M
Enterprise Value	$124M	$99M
Price	$9.48	$0.70
P/E Ratio	N/A	N/A
P/S Ratio	13.79x	6.52x
EV/Sales	19.98x	0.00x
EV/EBITDA	3.51x	227.13x
P/B Ratio	12.86x	17.75x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.65x	-782.53x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	14.78x	N/A
Forward P/S (NTM)	2.47x	N/A
Revenue & Growth
Revenue (TTM)	$6M	$0
Revenue Growth (YoY)	-96.7%	N/A
Forward Rev Growth	1983.2%	0.0%
Profitability
Gross Margin (TTM)	91.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-194.7%	0.0%
Net Margin (TTM)	-269.4%	0.0%
FCF Margin (TTM)	-353.5%	N/A
Net Income (TTM)	$-17M	$-51K
FCF (TTM)	$-22M	$-127K
EPS (TTM)	-$1.11	$0.00
ROE (TTM)	-31542.0%	2453.5%
ROA (TTM)	-7301.0%	-349482.0%
ROIC (TTM)	-30684.0%	2453.5%
Financial Health
Cash	$3M	$29K
Debt	$42M	$252K
Net Cash/Debt	$-38M	$-224K
Current Ratio (TTM)	1.98x	0.08x
Quick Ratio (TTM)	1.98x	0.08x
Debt/Equity (TTM)	0.12x	0.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.31	-349.46
52W Performance	-40.2%	438.5%
YTD Performance	-46.7%	-29.3%
% from 52W High	-50.5%	-39.1%
% from 52W Low	141.8%	699900.0%
Efficiency & Yields
Asset Turnover (TTM)	0.27x	0.79x
FCF Yield (TTM)	-25.6%	-0.1%
Earnings Yield (TTM)	-19.5%	-0.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-450.2	0.0
EV/GP/RG	0.05	N/A
Ticker research	View ATRA research	View HSTC research

Valuation

P/S Ratio

HSTC

6.52x

ATRA

13.79x

EV/FCF

HSTC

-782.53x

ATRA

-5.65x

Growth & revenue

Revenue Growth TTM

ATRA

-96.7%

Forward Revenue Growth

ATRA

1983.2%

HSTC

0.0%

Profitability & performance

Gross Margin

ATRA

91.4%

HSTC

0.0%

ROE

HSTC

2453.5%

ATRA

-31542.0%

FCF Yield %

HSTC

-0.1%

ATRA

-25.6%

52-Week Performance

HSTC

438.5%

ATRA

-40.2%

Detailed metrics comparison

ATRA

Atara Biotherapeutics Inc

HSTC

HST Global Inc

Market Cap

ATRA$85M

HSTC$99M

Enterprise Value

ATRA$124M

HSTC$99M

Price

ATRA$9.48

HSTC$0.70

P/E Ratio

ATRAN/A

HSTCN/A

P/S Ratio

ATRA13.79x

HSTC6.52x

EV/Sales

ATRA19.98x

HSTC0.00x

EV/EBITDA

ATRA3.51x

HSTC227.13x

P/B Ratio

ATRA12.86x

HSTC17.75x

P/FCF Ratio

ATRAN/A

HSTCN/A

EV/FCF

ATRA-5.65x

HSTC-782.53x

PEG Ratio

ATRAN/A

HSTCN/A

Forward P/E (NTM)

ATRA14.78x

HSTCN/A

Forward P/S (NTM)

ATRA2.47x

HSTCN/A

Revenue (TTM)

ATRA$6M

HSTC$0

Revenue Growth (YoY)

ATRA-96.7%

HSTCN/A

Forward Rev Growth

ATRA1983.2%

HSTC0.0%

Gross Margin (TTM)

ATRA91.4%

HSTC0.0%

Operating Margin (TTM)

ATRA0.0%

HSTC0.0%

EBITDA Margin (TTM)

ATRA-194.7%

HSTC0.0%

Net Margin (TTM)

ATRA-269.4%

HSTC0.0%

FCF Margin (TTM)

ATRA-353.5%

HSTCN/A

Net Income (TTM)

ATRA$-17M

HSTC$-51K

FCF (TTM)

ATRA$-22M

HSTC$-127K

EPS (TTM)

ATRA-$1.11

HSTC$0.00

ROE (TTM)

ATRA-31542.0%

HSTC2453.5%

ROA (TTM)

ATRA-7301.0%

HSTC-349482.0%

ROIC (TTM)

ATRA-30684.0%

HSTC2453.5%

Cash

ATRA$3M

HSTC$29K

Debt

ATRA$42M

HSTC$252K

Net Cash/Debt

ATRA$-38M

HSTC$-224K

Current Ratio (TTM)

ATRA1.98x

HSTC0.08x

Quick Ratio (TTM)

ATRA1.98x

HSTC0.08x

Debt/Equity (TTM)

ATRA0.12x

HSTC0.05x

Debt/Assets (TTM)

ATRA0.0%

HSTC0.0%

Interest Coverage (TTM)

ATRAN/A

HSTCN/A

Net Debt/EBITDA (TTM)

ATRA0.00x

HSTC0.00x

Beta

ATRA0.31

HSTC-349.46

52W Performance

ATRA-40.2%

HSTC438.5%

YTD Performance

ATRA-46.7%

HSTC-29.3%

% from 52W High

ATRA-50.5%

HSTC-39.1%

% from 52W Low

ATRA141.8%

HSTC699900.0%

Asset Turnover (TTM)

ATRA0.27x

HSTC0.79x

FCF Yield (TTM)

ATRA-25.6%

HSTC-0.1%

Earnings Yield (TTM)

ATRA-19.5%

HSTC-0.1%

Dividend Yield (TTM)

ATRAN/A

HSTCN/A

Rule of 40

ATRA-450.2

HSTC0.0

EV/GP/RG

ATRA0.05

HSTCN/A

Ticker research

View ATRA research View HSTC research

Metric	ATRA Atara Biotherapeutics Inc	HSTC HST Global Inc
Market & Valuation
Market Cap	$85M	$99M
Enterprise Value	$124M	$99M
Price	$9.48	$0.70
P/E Ratio	N/A	N/A
P/S Ratio	13.79x	6.52x
EV/Sales	19.98x	0.00x
EV/EBITDA	3.51x	227.13x
P/B Ratio	12.86x	17.75x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.65x	-782.53x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	14.78x	N/A
Forward P/S (NTM)	2.47x	N/A
Revenue & Growth
Revenue (TTM)	$6M	$0
Revenue Growth (YoY)	-96.7%	N/A
Forward Rev Growth	1983.2%	0.0%
Profitability
Gross Margin (TTM)	91.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-194.7%	0.0%
Net Margin (TTM)	-269.4%	0.0%
FCF Margin (TTM)	-353.5%	N/A
Net Income (TTM)	$-17M	$-51K
FCF (TTM)	$-22M	$-127K
EPS (TTM)	-$1.11	$0.00
ROE (TTM)	-31542.0%	2453.5%
ROA (TTM)	-7301.0%	-349482.0%
ROIC (TTM)	-30684.0%	2453.5%
Financial Health
Cash	$3M	$29K
Debt	$42M	$252K
Net Cash/Debt	$-38M	$-224K
Current Ratio (TTM)	1.98x	0.08x
Quick Ratio (TTM)	1.98x	0.08x
Debt/Equity (TTM)	0.12x	0.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.31	-349.46
52W Performance	-40.2%	438.5%
YTD Performance	-46.7%	-29.3%
% from 52W High	-50.5%	-39.1%
% from 52W Low	141.8%	699900.0%
Efficiency & Yields
Asset Turnover (TTM)	0.27x	0.79x
FCF Yield (TTM)	-25.6%	-0.1%
Earnings Yield (TTM)	-19.5%	-0.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-450.2	0.0
EV/GP/RG	0.05	N/A
Ticker research	View ATRA research	View HSTC research